Human factors testing of the levodopa-carbidopa intestinal gel delivery system in advanced Parkinson's disease patients and healthcare providers

被引:0
|
作者
Rodriguez, Ramon
Fernandez, Hubert
Espay, Alberto
Conjeevaram, Rajkumar
Zhou, Ji
Kuntz, Matthew
Halpern, Edward
Benesh, Janet
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
76
引用
收藏
页码:S35 / S35
页数:1
相关论文
共 50 条
  • [41] Reply to Letter: Suicide in Parkinson's Disease Patients Treated With Levodopa-Carbidopa Intestinal Gel
    Fernandez, Hubert H.
    Standaert, David G.
    Chatamra, Krai
    Benesh, Janet A.
    MOVEMENT DISORDERS, 2015, 30 (10) : 1435 - 1436
  • [42] Weight variation in Parkinson's disease patients treated with levodopa-carbidopa intestinal gel infusion
    Fernandez-Rodriguez, B.
    Dupouy, J.
    Harroch, E.
    Fabre-Delcros, M. H.
    Barthelemy, C.
    Loubiere, P.
    Barange, K.
    Brefel-Courbon, C.
    Rascol, O.
    Ory-Magne, F.
    MOVEMENT DISORDERS, 2018, 33 : S137 - S137
  • [43] Clinical features and survival of treatment with Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease.
    Mendoza, M. A. P.
    Contreras, A.
    Lafuente, G.
    Luque Buzo, E.
    De la Casa Fages, B.
    Gonzalez, M.
    Perez Sanchez, J.
    Grandas Perez, F.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 836 - 836
  • [44] Updated Long-Term Safety of Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease
    Rodriguez, Ramon
    Schmulewitz, Nathan
    Stein, David
    Robieson, Weining
    Hall, Coleen
    Eaton, Susan
    Chatamra, Krai
    Benesh, Janet
    Espay, Alberto J.
    ANNALS OF NEUROLOGY, 2015, 78 : S56 - S56
  • [45] The pharmacokinetics of patients with Parkinson's disease receiving levodopa-carbidopa intestinal gel infusion therapy
    Mukai, Y.
    Miyazaki, M.
    Mukai, T.
    Tasaki, A.
    Yuji, T.
    Murata, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 586 - 586
  • [46] Does continuous delivery of levodopa-carbidopa intestinal gel really improve levodopa induced dyskinesia in severe Parkinson's Disease patients?
    Colin, O.
    Benatru, I.
    Ouerdani, A.
    Lafay-Chebassier, C.
    Houeto, J. L.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 14 - 14
  • [47] Correction to: The TANDEM investigation: efficacy and tolerability of levodopa-carbidopa intestinal gel in (LCIG) advanced Parkinson’s disease patients
    Angelo Antonini
    Giovanni Abbruzzese
    Alfredo Berardelli
    Nicola Modugno
    Italo Stroppa
    Filippo Tamma
    Mariachiara Sensi
    Francesca Mancini
    Giovanni Cossu
    Alessandro Stefani
    Nicola Tambasco
    Alessandro Tessitore
    Giovanni Fabbrini
    Francesco E. Pontieri
    Paolo Solla
    Anna Rita Bentivoglio
    Cristoforo Comi
    Brigida Minafra
    Giulio Riboldazzi
    Donato Melchionda
    Tommaso Martino
    Leonardo Lopiano
    Journal of Neural Transmission, 2021, 128 : 863 - 865
  • [48] A long-term study on effectiveness of levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease patients
    Chaudhuri, K. R.
    Antonini, A.
    Poewe, W.
    Standaert, D.
    Odin, P.
    Zamudio, J.
    Bergmann, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 : 315 - 316
  • [49] Long-term effectiveness of levodopa-carbidopa intestinal gel in 177 Spanish patients with advanced Parkinson's disease
    Valldeoriola, Francesc
    Grandas, Francisco
    Santos-Garcia, Diego
    Regidor, Ignacio
    Catalan, Maria Jose
    Arbelo, Jose Matias
    Puente, Victor
    Mir, Pablo
    Parra, Juan Carlos
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2016, 6 (04) : 289 - 298
  • [50] Levodopa-carbidopa intestinal gel in advanced Parkinson's: Final results of the GLORIA registry
    Antonini, Angelo
    Poewe, Werner
    Chaudhuri, K. Ray
    Jech, Robert
    Pickut, Barbara
    Pirtosek, Zvezdan
    Szasz, Jozsef
    Valldeoriola, Francesc
    Winkler, Christian
    Bergmann, Lars
    Yegin, Ashley
    Onuk, Koray
    Barch, David
    Odin, Per
    PARKINSONISM & RELATED DISORDERS, 2017, 45 : 13 - 20